MMEDF News and Press, Mind Medicine From 03/03/21

MindMed's CEO has sold almost 25% of his shares in recent months. Tabernanthalog, 18-MAC, ME-18-MC could erode 18-MC's potential. Conducting LSD-assisted psychotherapy via videoconferencing is potentially hazardous and could result in lawsuits. The underlying fundamental poten...

MindMed Closes Acquisition of HealthMode, a Leading Machine Learning Digital Medicine Company Canada NewsWire Acquisition will help build a full stack digital mental health platform for psychedelic medicines; Ex-Pfizer Digital Medicine Executive Dr. Daniel R. Karlin ...

Are These Biotech Penny Stocks On Your Watch List? I know it isn’t March yet but with only a few days left, it might be time to put together your list of penny stocks to watch. The markets declined strongly on Tuesday with broader sectors like tech dipping to some of the lowe...

Point Roberts, WA and Delta, BC - February 23, 2021 (Investorideas.com Newswire) Investorideas.com, a leading investor news resource on health and wellness stocks releases a sector snapshot looking at a health revolution taking place with the growing functional mushroom and psychedelic mush...

Psychedelic medicine biotech company MindMed (OTCQB: MMEDF) said it will acquire HealthMode for roughly C41 million. HealthMode is a digital medicine and therapeutics startup that uses Artificial Intelligence (AI)-enabled digital measurement to increase the precision and...

Since launching in 2015, Canada’s NEO Exchange has distinguished itself to investors by providing exposure to novel industries such as the US cannabis market and the psychedelics space. Now the exchange is highlighting a growing presence in tech investments. Jos Schmi...

Psychedelic medicine-focused biotech MindMed (MMEDF) will acquire HealthMode, giving the former access to artificial intelligence-enabled digital measurement to enhance clinical research and patient monitoring.Under the terms, MindMed will acquire HealthMode through the issuance of 82,508 mul...

MindMed (OTCQB: MMEDF) (NEO: MMED) (DE: MMQ) , a leading psychedelic medicine biotech company, announced that it will acquire HealthMode, a digital medicine and therapeutics startup that uses Artificial Intelligence (AI)-enabled digital measurement to increase the precision an...

Psychedelic medicine biotech company MindMed (OTCQB: MMEDF) will acquire HealthMode, a digital medicine and therapeutics startup that uses Artificial Intelligence (AI)-enabled digital measurement to increase the precision and speed of clinical research and patient monitoring. ...

MindMed Reaches Agreement to Acquire HealthMode, a Leading Machine Learning Digital Medicine Company Canada NewsWire Acquisition will help build a full stack digital mental health platform for psychedelic medicines; Ex-Pfizer Digital Medicine Executive Dr. Daniel R. Ka...